Tammenoms Bakker Juliet

SEC source: 0001140361-18-031069 · form4.xml · nonDerivative · entry 2

Longitude Capital Partners II, LLC · CIK 0001647491 · 10% owner

Longitude Venture Partners II, L.P. · CIK 0001527510 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

ENRIGHT PATRICK G · CIK 0001253886 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Longitude Venture Partners II, L.P.

Disclosed balance after: 2,888,155

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock was convertible at any time at the option of the holder into Common Stock at a rate of 1/3.98, for no additional consideration, and had no expiration date. Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock, at a rate of 1/3.98 and for no additional consideration, upon closing of the Issuer's initial public offering of its Common Stock.

F2 · ownership.direct: These shares are held directly by Longitude Venture Partners II, L.P. ("Longitude II"). This statement is filed jointly by Longitude Capital Partners II, LLC ("LCP2"), Longitude II, Patrick G. Enright ("Mr. Enright") and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom share beneficial ownership of more than 10% of the capital stock of the Issuer. LCP2 is the general partner of Longitude II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II. Mr. Enright and Ms. Bakker are the managing members of LCP2 and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II.

F3 · ownership.direct: Each of LCP2, Mr. Enright and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its, his or her pecuniary interest therein, and the filing of this statement shall not be deemed an admission that any such Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F2 · ownership.nature: These shares are held directly by Longitude Venture Partners II, L.P. ("Longitude II"). This statement is filed jointly by Longitude Capital Partners II, LLC ("LCP2"), Longitude II, Patrick G. Enright ("Mr. Enright") and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom share beneficial ownership of more than 10% of the capital stock of the Issuer. LCP2 is the general partner of Longitude II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II. Mr. Enright and Ms. Bakker are the managing members of LCP2 and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II.

F3 · ownership.nature: Each of LCP2, Mr. Enright and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its, his or her pecuniary interest therein, and the filing of this statement shall not be deemed an admission that any such Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001140361-18-031069 · form4.xml · nonDerivative · entry 1

Longitude Capital Partners II, LLC · CIK 0001647491 · 10% owner

Longitude Venture Partners II, L.P. · CIK 0001527510 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

ENRIGHT PATRICK G · CIK 0001253886 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Longitude Venture Partners II, L.P.

Disclosed balance after: 2,431,511

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock was convertible at any time at the option of the holder into Common Stock at a rate of 1/3.98, for no additional consideration, and had no expiration date. Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock, at a rate of 1/3.98 and for no additional consideration, upon closing of the Issuer's initial public offering of its Common Stock.

F2 · ownership.direct: These shares are held directly by Longitude Venture Partners II, L.P. ("Longitude II"). This statement is filed jointly by Longitude Capital Partners II, LLC ("LCP2"), Longitude II, Patrick G. Enright ("Mr. Enright") and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom share beneficial ownership of more than 10% of the capital stock of the Issuer. LCP2 is the general partner of Longitude II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II. Mr. Enright and Ms. Bakker are the managing members of LCP2 and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II.

F3 · ownership.direct: Each of LCP2, Mr. Enright and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its, his or her pecuniary interest therein, and the filing of this statement shall not be deemed an admission that any such Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F2 · ownership.nature: These shares are held directly by Longitude Venture Partners II, L.P. ("Longitude II"). This statement is filed jointly by Longitude Capital Partners II, LLC ("LCP2"), Longitude II, Patrick G. Enright ("Mr. Enright") and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom share beneficial ownership of more than 10% of the capital stock of the Issuer. LCP2 is the general partner of Longitude II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II. Mr. Enright and Ms. Bakker are the managing members of LCP2 and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude II.

F3 · ownership.nature: Each of LCP2, Mr. Enright and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its, his or her pecuniary interest therein, and the filing of this statement shall not be deemed an admission that any such Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001104659-18-042312 · a4.xml · derivative · entry 7

Longitude Capital Partners II, LLC · CIK 0001647491 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Venture Partners II, L.P. · CIK 0001527510 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By: Longitude Venture Partners II, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 795,553 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F1 · price: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F1 · derivative.expiration_date: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F2 · ownership.nature: This statement is filed jointly by Longitude Capital Partners II, LLC ("Longitude Capital II"), Longitude Venture Partners II, L.P. ("Longitude Venture II"), and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom shared beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the transactions reported in this statement (but all of whom have ceased to share beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the filing of this statement and, as a result, are no longer subject to Section 16 of the Securities Exchange Act of 1934, as amended). The shares reported in this statement are held directly by Longitude Venture II. Longitude Capital II is the general partner of Longitude Venture II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude Venture II.

F3 · ownership.nature: Ms. Bakker is a managing member of Longitude Capital II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude Venture II. Each of Longitude Capital II and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its or her pecuniary interest therein.

SEC source: 0001104659-18-042312 · a4.xml · derivative · entry 6

Longitude Capital Partners II, LLC · CIK 0001647491 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Venture Partners II, L.P. · CIK 0001527510 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By: Longitude Venture Partners II, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 1,197,076 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F1 · price: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F1 · derivative.expiration_date: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F2 · ownership.nature: This statement is filed jointly by Longitude Capital Partners II, LLC ("Longitude Capital II"), Longitude Venture Partners II, L.P. ("Longitude Venture II"), and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom shared beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the transactions reported in this statement (but all of whom have ceased to share beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the filing of this statement and, as a result, are no longer subject to Section 16 of the Securities Exchange Act of 1934, as amended). The shares reported in this statement are held directly by Longitude Venture II. Longitude Capital II is the general partner of Longitude Venture II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude Venture II.

F3 · ownership.nature: Ms. Bakker is a managing member of Longitude Capital II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude Venture II. Each of Longitude Capital II and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its or her pecuniary interest therein.

SEC source: 0001104659-18-042312 · a4.xml · derivative · entry 5

Longitude Capital Partners II, LLC · CIK 0001647491 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Venture Partners II, L.P. · CIK 0001527510 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By: Longitude Venture Partners II, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 1,047,450 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F1 · price: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F1 · derivative.expiration_date: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F2 · ownership.nature: This statement is filed jointly by Longitude Capital Partners II, LLC ("Longitude Capital II"), Longitude Venture Partners II, L.P. ("Longitude Venture II"), and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom shared beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the transactions reported in this statement (but all of whom have ceased to share beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the filing of this statement and, as a result, are no longer subject to Section 16 of the Securities Exchange Act of 1934, as amended). The shares reported in this statement are held directly by Longitude Venture II. Longitude Capital II is the general partner of Longitude Venture II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude Venture II.

F3 · ownership.nature: Ms. Bakker is a managing member of Longitude Capital II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude Venture II. Each of Longitude Capital II and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its or her pecuniary interest therein.

SEC source: 0001104659-18-042312 · a4.xml · nonDerivative · entry 4

Longitude Capital Partners II, LLC · CIK 0001647491 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Venture Partners II, L.P. · CIK 0001527510 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By: Longitude Venture Partners II, L.P.

Disclosed balance after: 3,190,079

F4 · shares: On June 25, 2018, Longitude Venture II purchased 150,000 shares of Common Stock of the Issuer at a price of $16.00 per share in the Issuer's initial public offering.

F2 · ownership.nature: This statement is filed jointly by Longitude Capital Partners II, LLC ("Longitude Capital II"), Longitude Venture Partners II, L.P. ("Longitude Venture II"), and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom shared beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the transactions reported in this statement (but all of whom have ceased to share beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the filing of this statement and, as a result, are no longer subject to Section 16 of the Securities Exchange Act of 1934, as amended). The shares reported in this statement are held directly by Longitude Venture II. Longitude Capital II is the general partner of Longitude Venture II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude Venture II.

F3 · ownership.nature: Ms. Bakker is a managing member of Longitude Capital II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude Venture II. Each of Longitude Capital II and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its or her pecuniary interest therein.

SEC source: 0001104659-18-042312 · a4.xml · nonDerivative · entry 3

Longitude Capital Partners II, LLC · CIK 0001647491 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Venture Partners II, L.P. · CIK 0001527510 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By: Longitude Venture Partners II, L.P.

Disclosed balance after: 3,040,079

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F1 · price: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F2 · ownership.nature: This statement is filed jointly by Longitude Capital Partners II, LLC ("Longitude Capital II"), Longitude Venture Partners II, L.P. ("Longitude Venture II"), and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom shared beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the transactions reported in this statement (but all of whom have ceased to share beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the filing of this statement and, as a result, are no longer subject to Section 16 of the Securities Exchange Act of 1934, as amended). The shares reported in this statement are held directly by Longitude Venture II. Longitude Capital II is the general partner of Longitude Venture II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude Venture II.

F3 · ownership.nature: Ms. Bakker is a managing member of Longitude Capital II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude Venture II. Each of Longitude Capital II and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its or her pecuniary interest therein.

SEC source: 0001104659-18-042312 · a4.xml · nonDerivative · entry 2

Longitude Capital Partners II, LLC · CIK 0001647491 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Venture Partners II, L.P. · CIK 0001527510 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By: Longitude Venture Partners II, L.P.

Disclosed balance after: 2,244,526

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F1 · price: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F2 · ownership.nature: This statement is filed jointly by Longitude Capital Partners II, LLC ("Longitude Capital II"), Longitude Venture Partners II, L.P. ("Longitude Venture II"), and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom shared beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the transactions reported in this statement (but all of whom have ceased to share beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the filing of this statement and, as a result, are no longer subject to Section 16 of the Securities Exchange Act of 1934, as amended). The shares reported in this statement are held directly by Longitude Venture II. Longitude Capital II is the general partner of Longitude Venture II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude Venture II.

F3 · ownership.nature: Ms. Bakker is a managing member of Longitude Capital II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude Venture II. Each of Longitude Capital II and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its or her pecuniary interest therein.

SEC source: 0001104659-18-042312 · a4.xml · nonDerivative · entry 1

Longitude Capital Partners II, LLC · CIK 0001647491 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Venture Partners II, L.P. · CIK 0001527510 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By: Longitude Venture Partners II, L.P.

Disclosed balance after: 1,047,450

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F1 · price: Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.

F2 · ownership.nature: This statement is filed jointly by Longitude Capital Partners II, LLC ("Longitude Capital II"), Longitude Venture Partners II, L.P. ("Longitude Venture II"), and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom shared beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the transactions reported in this statement (but all of whom have ceased to share beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the filing of this statement and, as a result, are no longer subject to Section 16 of the Securities Exchange Act of 1934, as amended). The shares reported in this statement are held directly by Longitude Venture II. Longitude Capital II is the general partner of Longitude Venture II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude Venture II.

F3 · ownership.nature: Ms. Bakker is a managing member of Longitude Capital II and may be deemed to share voting and investment power over the shares of the Issuer held by Longitude Venture II. Each of Longitude Capital II and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its or her pecuniary interest therein.

SEC source: 0001209191-18-013353 · doc4.xml · nonDerivative · entry 1

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,651

F1 · shares: The shares were purchased in the Issuer's underwritten public offering closed on February 26, 2018.

SEC source: 0001209191-17-065191 · doc4.xml · nonDerivative · entry 2

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

ENRIGHT PATRICK G · CIK 0001253886 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LCA

Disclosed balance after: 45,620

F1 · ownership.nature: This report is filed jointly by Longitude Capital Partners, LLC ("LCP"), Longitude Venture Partners, L.P. ("LVP"), Longitude Capital Associates, L.P. ("LCA"), Patrick G. Enright ("Enright") and Juliet Tammenoms Bakker ("Bakker"). LCP is the general partner of LVP and LCA, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of Enright and Bakker is a managing member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of LCP, Enright and Bakker disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-17-065191 · doc4.xml · nonDerivative · entry 1

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

ENRIGHT PATRICK G · CIK 0001253886 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LVP

Disclosed balance after: 2,276,222

F1 · ownership.nature: This report is filed jointly by Longitude Capital Partners, LLC ("LCP"), Longitude Venture Partners, L.P. ("LVP"), Longitude Capital Associates, L.P. ("LCA"), Patrick G. Enright ("Enright") and Juliet Tammenoms Bakker ("Bakker"). LCP is the general partner of LVP and LCA, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of Enright and Bakker is a managing member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of LCP, Enright and Bakker disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-17-046462 · doc4.xml · derivative · entry 3

Longitude Capital Partners II, LLC · CIK 0001647491 · 10% owner

ENRIGHT PATRICK G · CIK 0001253886 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Venture Partners II, L.P. · CIK 0001527510 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Longitude Venture Partners II, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 2,055,946 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Series C Preferred Stock converted into Common Stock on a 5.2083-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F1 · derivative.exercise_date: The Series C Preferred Stock converted into Common Stock on a 5.2083-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F1 · derivative.expiration_date: The Series C Preferred Stock converted into Common Stock on a 5.2083-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F2 · ownership.nature: This Form 4 is filed jointly by Longitude Capital Partners II, LLC ("Longitude Capital II"), Longitude Venture Partners II, L.P. ("Longitude Venture II"), Patrick G. Enright ("Mr. Enright") and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom shared beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the transactions reported in this Form 4. Longitude Capital II is the general partner of Longitude Venture II and may be deemed to share voting and investment power over the shares held by Longitude Venture II. Mr. Enright and Ms. Bakker are the managing members of Longitude Capital II and may be deemed to share voting and investment power over the shares held by Longitude Venture II. Each of Longitude Capital II, Mr. Enright and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its, his or her pecuniary interest therein.

F3 · ownership.nature: Longitude Venture II acquired 215,000 shares of Common Stock in the Issuer's initial public offering.

SEC source: 0001209191-17-046462 · doc4.xml · nonDerivative · entry 2

Longitude Capital Partners II, LLC · CIK 0001647491 · 10% owner

ENRIGHT PATRICK G · CIK 0001253886 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Venture Partners II, L.P. · CIK 0001527510 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Longitude Venture Partners II, L.P.

Disclosed balance after: 2,270,946

F2 · ownership.nature: This Form 4 is filed jointly by Longitude Capital Partners II, LLC ("Longitude Capital II"), Longitude Venture Partners II, L.P. ("Longitude Venture II"), Patrick G. Enright ("Mr. Enright") and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom shared beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the transactions reported in this Form 4. Longitude Capital II is the general partner of Longitude Venture II and may be deemed to share voting and investment power over the shares held by Longitude Venture II. Mr. Enright and Ms. Bakker are the managing members of Longitude Capital II and may be deemed to share voting and investment power over the shares held by Longitude Venture II. Each of Longitude Capital II, Mr. Enright and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its, his or her pecuniary interest therein.

F3 · ownership.nature: Longitude Venture II acquired 215,000 shares of Common Stock in the Issuer's initial public offering.

SEC source: 0001209191-17-046462 · doc4.xml · nonDerivative · entry 1

Longitude Capital Partners II, LLC · CIK 0001647491 · 10% owner

ENRIGHT PATRICK G · CIK 0001253886 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Venture Partners II, L.P. · CIK 0001527510 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Longitude Venture Partners II, L.P.

Disclosed balance after: 2,055,946

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Series C Preferred Stock converted into Common Stock on a 5.2083-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.

F2 · ownership.nature: This Form 4 is filed jointly by Longitude Capital Partners II, LLC ("Longitude Capital II"), Longitude Venture Partners II, L.P. ("Longitude Venture II"), Patrick G. Enright ("Mr. Enright") and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom shared beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the transactions reported in this Form 4. Longitude Capital II is the general partner of Longitude Venture II and may be deemed to share voting and investment power over the shares held by Longitude Venture II. Mr. Enright and Ms. Bakker are the managing members of Longitude Capital II and may be deemed to share voting and investment power over the shares held by Longitude Venture II. Each of Longitude Capital II, Mr. Enright and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its, his or her pecuniary interest therein.

F3 · ownership.nature: Longitude Venture II acquired 215,000 shares of Common Stock in the Issuer's initial public offering.

SEC source: 0001209191-16-155808 · doc4.xml · nonDerivative · entry 1

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,539

SEC source: 0001209191-16-155279 · doc4.xml · nonDerivative · entry 1

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,210

F1 · kind: On November 28, 2016, Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Partners, L.P. ("LCA") completed a pro rata distribution of shares of common stock of the Issuer to its partners for no consideration. Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP and LCA, received a pro rata allocation of the distributed shares in accordance with its ownership, and on December 12, 2016, further distributed its allocation to its managing members. Juliet Tammenoms Bakker, as a managing member of Longitude Capital, acquired the shares noted in this Form through such distribution.

SEC source: 0001209191-16-152812 · doc4.xml · nonDerivative · entry 2

Longitude Capital Partners II, LLC · CIK 0001647491 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Venture Partners II, L.P. · CIK 0001527510 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,276

F1 · kind: Represents a pro rata distribution from Longitude Venture Partners II, L.P. ("Longitude Venture II") to its partners for no consideration. Longitude Capital Partners II, LLC ("Longitude Capital II"), the sole general partner of Longitude Venture II, received a pro rata allocation of the distributed shares in accordance with its ownership, and further distributed its allocation to its managing members.

F3 · balance_after: Following the pro rata distribution described in Footnote 1, these shares became directly beneficially owned by Ms. Bakker. Neither Longitude Capital II nor Longitude Venture II has voting, investment or dispositive power over any of the shares directly held by Ms. Bakker and disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any, and this report shall not be deemed an admission that Longitude Capital II and Longitude Venture II are the beneficial owners of these shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001209191-16-152812 · doc4.xml · nonDerivative · entry 1

Longitude Capital Partners II, LLC · CIK 0001647491 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Venture Partners II, L.P. · CIK 0001527510 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Longitude Venture Partners II, L.P.

Disclosed balance after: 6,013,134

F1 · kind: Represents a pro rata distribution from Longitude Venture Partners II, L.P. ("Longitude Venture II") to its partners for no consideration. Longitude Capital Partners II, LLC ("Longitude Capital II"), the sole general partner of Longitude Venture II, received a pro rata allocation of the distributed shares in accordance with its ownership, and further distributed its allocation to its managing members.

F2 · ownership.nature: This report is filed jointly by Longitude Capital II, Longitude Venture II, and Juliet Tammenoms Bakker, a managing member of Longitude Capital II, with respect to the securities held and transactions effected by Longitude Venture II. Patrick G. Enright, a managing member of Longitude Capital II, currently serves on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital II and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-152569 · doc4.xml · nonDerivative · entry 2

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LCA

Disclosed balance after: 121,153

F3 · kind: Represents a pro rata distribution from LCA to its partners for no consideration. LCP, which is the sole general partner of LCA, received a pro rata allocation of the distributed shares in accordance with its ownership.

F4 · ownership.nature: Reflects transactions and holdings of shares of common stock of the Issuer held of record by LCA. This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-152569 · doc4.xml · nonDerivative · entry 1

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,834,849

F1 · kind: Represents a pro rata distribution from Longitude Venture Partners, L.P. ("LVP") to its partners for no consideration. Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP, received a pro rata allocation of the distributed shares in accordance with its ownership.

F2 · ownership.direct: Reflects transactions and holdings of shares of common stock of the Issuer held of record by LVP. This report is filed jointly by LVP, Longitude Capital, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-152057 · doc4.xml · nonDerivative · entry 6

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LCA

Disclosed balance after: 180,103

F5 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.3000 to $9.4600. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F3 · ownership.nature: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-152057 · doc4.xml · nonDerivative · entry 5

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,775,899

F5 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.3000 to $9.4600. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F2 · ownership.direct: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). This report is filed jointly by LVP, Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-152057 · doc4.xml · nonDerivative · entry 4

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LCA

Disclosed balance after: 180,393

F4 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.3000 to $9.3400. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F3 · ownership.nature: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-152057 · doc4.xml · nonDerivative · entry 3

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,790,350

F4 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.3000 to $9.3400. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F2 · ownership.direct: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). This report is filed jointly by LVP, Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-152057 · doc4.xml · nonDerivative · entry 2

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LCA

Disclosed balance after: 180,641

F1 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.300 to $9.3600. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F3 · ownership.nature: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-152057 · doc4.xml · nonDerivative · entry 1

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,802,702

F1 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.300 to $9.3600. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F2 · ownership.direct: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). This report is filed jointly by LVP, Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-151526 · doc4.xml · nonDerivative · entry 6

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LCA

Disclosed balance after: 180,830

F5 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.3300 to $9.4800. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F3 · ownership.nature: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-151526 · doc4.xml · nonDerivative · entry 5

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,812,113

F5 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.3300 to $9.4800. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F2 · ownership.direct: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). This report is filed jointly by LVP, Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-151526 · doc4.xml · nonDerivative · entry 4

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LCA

Disclosed balance after: 183,157

F4 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.4500 to $9.5400. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F3 · ownership.nature: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-151526 · doc4.xml · nonDerivative · entry 3

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,928,171

F4 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.4500 to $9.5400. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F2 · ownership.direct: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). This report is filed jointly by LVP, Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-151526 · doc4.xml · nonDerivative · entry 2

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LCA

Disclosed balance after: 185,133

F1 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.5300 to $9.8000. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F3 · ownership.nature: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-151526 · doc4.xml · nonDerivative · entry 1

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,026,757

F1 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.5300 to $9.8000. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F2 · ownership.direct: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). This report is filed jointly by LVP, Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-151019 · doc4.xml · nonDerivative · entry 4

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LCA

Disclosed balance after: 191,522

F4 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.5000 to $9.5450. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F3 · ownership.nature: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-151019 · doc4.xml · nonDerivative · entry 3

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,345,521

F4 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.5000 to $9.5450. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F2 · ownership.direct: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). This report is filed jointly by LVP, Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-151019 · doc4.xml · nonDerivative · entry 2

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LCA

Disclosed balance after: 191,864

F1 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.5000 to $9.7200. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F3 · ownership.nature: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). This report is jointly filed by LCA, Longitude Capital, the sole general partner of LCA, and Ms. Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.

SEC source: 0001209191-16-151019 · doc4.xml · nonDerivative · entry 1

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,362,573

F1 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $9.5000 to $9.7200. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.

F2 · ownership.direct: Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). This report is filed jointly by LVP, Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP, and Juliet Tammenoms Bakker, a managing member of Longitude Capital, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.